These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1358767)

  • 1. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
    Lehy T; Cadiot G; Mignon M; Ruszniewski P; Bonfils S
    Gut; 1992 Sep; 33(9):1275-9. PubMed ID: 1358767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
    Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
    Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.
    Cadiot G; Lehy T; Ruszniewski P; Bonfils S; Mignon M
    Dig Dis Sci; 1993 Jul; 38(7):1307-17. PubMed ID: 8100759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome.
    Cadiot G; Vissuzaine C; Potet F; Mignon M
    Dig Dis Sci; 1995 Jun; 40(6):1275-8. PubMed ID: 7781446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
    Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
    Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.
    Lehy T; Mignon M; Cadiot G; Elouaer-Blanc L; Ruszniewski P; Lewin MJ; Bonfils S
    Gastroenterology; 1989 Apr; 96(4):1029-40. PubMed ID: 2925050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.
    Cadiot G; Lehy T; Mignon M
    Acta Oncol; 1993; 32(2):135-40. PubMed ID: 8323754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
    Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
    Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
    Cadiot G; Laurent-Puig P; Thuille B; Lehy T; Mignon M; Olschwang S
    Gastroenterology; 1993 Aug; 105(2):579-82. PubMed ID: 8101501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.
    Annibale B; Delle Fave G; Azzoni C; Corleto V; Camboni G; D'Ambra G; Pilato FP; Bordi C
    Aliment Pharmacol Ther; 1994 Feb; 8(1):95-104. PubMed ID: 7910489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.
    Mignon M; Lehy T; Bonnefond A; Ruszniewski P; Labeille D; Bonfils S
    Cancer; 1987 Jun; 59(11):1959-62. PubMed ID: 2436742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid gastrin and parathormone-producing tumour in the Zollinger-Ellison syndrome of MEN 1 origin.
    Santini D; Pasquinelli G; D'Alessandro L; Mazzoleni G; Taffurelli M; Campione O; Marrano D; Martinelli GN
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):433-7. PubMed ID: 1684256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
    Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
    N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
    Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
    J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.
    Betts JB; O'Malley BP; Rosenthal FD
    Q J Med; 1980; 49(193):69-76. PubMed ID: 6107954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
    Lehy T; Roucayrol AM; Mignon M
    Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Zollinger-Ellison syndrome due to an infiltrating tumour of the stomach.
    Royston CM; Brew DS; Garnham JR; Stagg BH; Polak J
    Gut; 1972 Aug; 13(8):638-42. PubMed ID: 4562021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.